Science
3 Things About CRISPR Therapeutics That Smart Investors Know – The Motley Fool
The company’s value isn’t reflected in typical performance metrics.
The gene-editing virtuoso CRISPR Therapeutics (NASDAQ:CRSP) is one of the most-watched stocks in biotech, and it’s no surprise why. CRISPR Therapeutics has a handful of different programs that could turn out to be low-risk cures for previously intractable…
Continue Reading
-
Noosa News14 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News20 hours agoQueensland Rail retires iconic electric train fleet after more than four decades
-
Business16 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News16 hours agoAustralia’s biggest sheep drive, and the young drover history forgot